Literature DB >> 19232714

Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration.

Diederik H R Kempen1, Lichun Lu, Andras Heijink, Theresa E Hefferan, Laura B Creemers, Avudaiappan Maran, Michael J Yaszemski, Wouter J A Dhert.   

Abstract

Bone regeneration is a coordinated cascade of events regulated by several cytokines and growth factors. Angiogenic growth factors are predominantly expressed during the early phases for re-establishment of the vascularity, whereas osteogenic growth factors are continuously expressed during bone formation and remodeling. Since vascular endothelial growth factor (VEGF) and bone morphogenetic proteins (BMPs) are key regulators of angiogenesis and osteogenesis during bone regeneration, the aim of this study was to investigate if their sequential release could enhance BMP-2-induced bone formation. A composite consisting of poly(lactic-co-glycolic acid) microspheres loaded with BMP-2 embedded in a poly(propylene) scaffold surrounded by a gelatin hydrogel loaded with VEGF was used for the sequential release of the growth factors. Empty composites or composites loaded with VEGF and/or BMP-2 were implanted ectopically and orthotopically in Sprague-Dawley rats (n=9). Following implantation, the local release profiles were determined by measuring the activity of (125)I-labeled growth factors using scintillation probes. After 8 weeks blood vessel and bone formation were analyzed using microangiography, microCT and histology. The scaffolds exhibited a large initial burst release of VEGF within the first 3 days and a sustained release of BMP-2 over the full 56-day implantation period. Although VEGF did not induce bone formation, it did increase the formation of the supportive vascular network (p=0.03) in ectopic implants. In combination with local sustained BMP-2 release, VEGF significantly enhanced ectopic bone formation compared to BMP-2 alone (p=0.008). In the orthotopic defects, no effect of VEGF on vascularisation was found, nor was bone formation higher by the combination of growth factors, compared to BMP-2 alone. This study demonstrates that a sequential angiogenic and osteogenic growth factor release may be beneficial for the enhancement of bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232714     DOI: 10.1016/j.biomaterials.2009.01.031

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  147 in total

1.  Controllable mineral coatings on PCL scaffolds as carriers for growth factor release.

Authors:  Darilis Suárez-González; Kara Barnhart; Francesco Migneco; Colleen Flanagan; Scott J Hollister; William L Murphy
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

Review 2.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

3.  Reciprocal induction of human dermal microvascular endothelial cells and human mesenchymal stem cells: time-dependent profile in a co-culture system.

Authors:  M S Laranjeira; M H Fernandes; F J Monteiro
Journal:  Cell Prolif       Date:  2012-05-18       Impact factor: 6.831

4.  Evaluation of dense polylactic acid/beta-tricalcium phosphate scaffolds for bone tissue engineering.

Authors:  Laura Yanoso-Scholl; Justin A Jacobson; Gino Bradica; Amy L Lerner; Regis J O'Keefe; Edward M Schwarz; Michael J Zuscik; Hani A Awad
Journal:  J Biomed Mater Res A       Date:  2010-12-01       Impact factor: 4.396

5.  Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel.

Authors:  Danial Barati; Seyed Ramin Pajoum Shariati; Seyedsina Moeinzadeh; Juan M Melero-Martin; Ali Khademhosseini; Esmaiel Jabbari
Journal:  J Control Release       Date:  2015-12-22       Impact factor: 9.776

6.  Injectable shear-thinning hydrogels for delivering osteogenic and angiogenic cells and growth factors.

Authors:  Emine Alarçin; Tae Yong Lee; Sobha Karuthedom; Marzieh Mohammadi; Meadhbh A Brennan; Dong Hoon Lee; Alessandra Marrella; Jin Zhang; Denata Syla; Yu Shrike Zhang; Ali Khademhosseini; Hae Lin Jang
Journal:  Biomater Sci       Date:  2018-05-29       Impact factor: 6.843

7.  Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects.

Authors:  A M Henslee; P P Spicer; D M Yoon; M B Nair; V V Meretoja; K E Witherel; J A Jansen; A G Mikos; F K Kasper
Journal:  Acta Biomater       Date:  2011-06-30       Impact factor: 8.947

8.  In Vitro and In Vivo Correlation of Bone Morphogenetic Protein-2 Release Profiles from Complex Delivery Vehicles.

Authors:  Maurits G L Olthof; Marianna A Tryfonidou; Mahrokh Dadsetan; Wouter J A Dhert; Michael J Yaszemski; Diederik H R Kempen; Lichun Lu
Journal:  Tissue Eng Part C Methods       Date:  2018-07       Impact factor: 3.056

9.  Bioerodible system for sequential release of multiple drugs.

Authors:  Sharath C Sundararaj; Mark V Thomas; Thomas D Dziubla; David A Puleo
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

10.  Ordered and kinetically discrete sequential protein release from biodegradable thin films.

Authors:  Bryan B Hsu; Kelsey S Jamieson; Samantha R Hagerman; Eggehard Holler; Julia Y Ljubimova; Paula T Hammond
Journal:  Angew Chem Int Ed Engl       Date:  2014-06-18       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.